I very much agree that unprofessional submissions would be counterproductive. My personal view is that one or two very high quality submissions from HC people might be useful. However, I think large numbers that add nothing could have a quite negative effect.
I think anyone considering lodging a submission should seriously consider some questions first:
* Can you add anything useful, or will any important decision makers feel like they have wasted their valuable time by reading your submission?
* What about you means your view is relevant to AdComm/FDA decision processes? Eg. Have you or a loved one suffered from GVHD? Are you a doctor who treats GVHD? Are you part of a patient advocacy group? Are you a research scientist or a stem cell expert? Are you an American resident or citizen (AdComm/FDA are answerable to the American public, not random Aussies)?
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-265
-
- There are more pages in this discussion • 590 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.210B |
Open | High | Low | Value | Volume |
$1.05 | $1.09 | $1.03 | $5.796M | 5.430M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 15990 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.08 | 48632 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 385 | 1.110 |
1 | 499 | 1.100 |
3 | 1410 | 1.065 |
4 | 46920 | 1.060 |
2 | 5771 | 1.050 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 5000 | 1 |
1.060 | 11223 | 2 |
1.075 | 18282 | 1 |
1.080 | 71785 | 3 |
1.085 | 94467 | 6 |
Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |